Middle East & Africa Cell and Gene Therapy Manufacturing Services Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - by Type [Cell Therapy (Autologous and Allogenic) and Gene Therapy (Viral and Non-Viral Vector)], Indication (Cancer, Orthopedics, and Others), Application (Clinical Manufacturing and Commercial Manufacturing), and End User [Pharmaceutical and Biotechnology Companies and Contract Research Organization (CROs)]

No. of Pages: 95    |    Report Code: BMIRE00029309    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Middle East & Africa Cell and Gene Therapy Manufacturing Services Market

TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Key Industry Dynamics
4.1 Key Market Drivers:
4.1.1 Increase in Number of Approval of Cell and Gene Therapies
4.1.2 Increasing Popularity of Outsourcing Cell and Gene Therapy Manufacturing
4.2 Market Restraints
4.2.1 High Cost of Cell and Gene Therapy Manufacturing
4.3 Market Opportunities
4.3.1 Strategic Initiatives by Companies
4.4 Future Trends
4.4.1 Automation of Cell and Gene Therapy Manufacturing Services
4.5 Impact Analysis:
5. Cell and Gene Therapy Manufacturing Services Market - Middle East & Africa Market Analysis
5.1 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Revenue (US$ Mn), 2022 - 2030
6. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 - by Type
6.1 Overview
6.2 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Revenue Share, by Type 2022 & 2030 (%)
6.3 Cell Therapy
6.3.1 Overview
6.3.2 Cell Therapy: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
6.3.2.1 Autologous
6.3.2.1.1 Overview
6.3.2.1.2 Autologous: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
6.3.2.2 Allogenic
6.3.2.2.1 Overview
6.3.2.2.2 Allogenic: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Gene Therapy
6.4.1 Overview
6.4.2 Gene Therapy: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
6.4.2.1 Viral Vector
6.4.2.1.1 Overview
6.4.2.1.2 Viral Vector: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
6.4.2.2 Non-Viral Vector
6.4.2.2.1 Overview
6.4.2.2.2 Non-Viral Vector: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
7. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Analysis and Forecasts to 2030 - by Indication
7.1 Overview
7.2 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Indication 2022 & 2030 (%)
7.3 Cancer
7.3.1 Overview
7.3.2 Cancer: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Orthopedics
7.4.1 Overview
7.4.2 Orthopedics: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
8. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 - by Application
8.1 Overview
8.2 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Revenue Share, by Application 2022 & 2030 (%)
8.4 Clinical Manufacturing
8.4.1 Overview
8.4.2 Clinical Manufacturing: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Commercial Manufacturing
8.5.1 Overview
8.5.2 Commercial Manufacturing: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
9. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 - by End User
9.1 Overview
9.2 Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Revenue Share, by End User 2022 & 2030 (%)
9.4 Pharmaceutical and Biotechnology Companies
9.4.1 Overview
9.4.2 Pharmaceutical & Biotechnology Companies: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Contract Research Organizations (CROs)
9.5.1 Overview
9.5.2 Contract Research Organizations (CROs): Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
10. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 - Country Analysis
10.1 Overview
10.1.1 Middle East & Africa: Cell and Gene Therapy Manufacturing Services Market, by Country, 2022 & 2030 (%)
10.1.1.1 South Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.1 South Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Type, 2020-2030 (US$ Million)
10.1.1.1.1.1 South Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020-2030 (US$ Million)
10.1.1.1.1.2 South Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020-2030 (US$ Million)
10.1.1.1.2 South Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020-2030 (US$ Million)
10.1.1.1.3 South Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Application, 2020-2030 (US$ Million)
10.1.1.1.4 South Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by End User, 2020-2030 (US$ Million)
10.1.1.2 Saudi Arabia: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.1 Saudi Arabia: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Type, 2020-2030 (US$ Million)
10.1.1.2.1.1 Saudi Arabia: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020-2030 (US$ Million)
10.1.1.2.1.2 Saudi Arabia: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020-2030 (US$ Million)
10.1.1.2.2 Saudi Arabia: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020-2030 (US$ Million)
10.1.1.2.3 Saudi Arabia: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Application, 2020-2030 (US$ Million)
10.1.1.2.4 Saudi Arabia: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by End User, 2020-2030 (US$ Million)
10.1.1.3 UAE: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.1 UAE: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Type, 2020-2030 (US$ Million)
10.1.1.3.1.1 UAE: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020-2030 (US$ Million)
10.1.1.3.1.2 UAE: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020-2030 (US$ Million)
10.1.1.3.2 UAE: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020-2030 (US$ Million)
10.1.1.3.3 UAE: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Application, 2020-2030 (US$ Million)
10.1.1.3.4 UAE: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by End User, 2020-2030 (US$ Million)
10.1.1.4 Rest of Middle East & Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.1 Rest of Middle East & Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Type, 2020-2030 (US$ Million)
10.1.1.4.1.1 Rest of Middle East & Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020-2030 (US$ Million)
10.1.1.4.1.2 Rest of Middle East & Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020-2030 (US$ Million)
10.1.1.4.2 Rest of Middle East & Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020-2030 (US$ Million)
10.1.1.4.3 Rest of Middle East & Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Application, 2020-2030 (US$ Million)
10.1.1.4.4 Rest of Middle East & Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by End User, 2020-2030 (US$ Million)
11. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Industry Landscape
11.1 Overview
11.2 Growth Strategies in Middle East & Africa Cell and Gene Therapy Manufacturing Services Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Thermo Fisher Scientific Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Merck KGaA
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Lonza Group AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 WuXi AppTec Co Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Nikon Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Takara Bio Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments



List of Tables
Table 1. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Segmentation
Table 2. South Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Type, 2020-2030 (US$ Million)
Table 3. South Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020-2030 (US$ Million)
Table 4. South Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020-2030 (US$ Million)
Table 5. South Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020-2030 (US$ Million)
Table 6. South Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Application, 2020-2030 (US$ Million)
Table 7. South Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by End User, 2020-2030 (US$ Million)
Table 8. Saudi Arabia: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Type, 2020-2030 (US$ Million)
Table 9. Saudi Arabia: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020-2030 (US$ Million)
Table 10. Saudi Arabia: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020-2030 (US$ Million)
Table 11. Saudi Arabia: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020-2030 (US$ Million)
Table 12. Saudi Arabia: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Application, 2020-2030 (US$ Million)
Table 13. Saudi Arabia: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by End User, 2020-2030 (US$ Million)
Table 14. UAE: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Type, 2020-2030 (US$ Million)
Table 15. UAE: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020-2030 (US$ Million)
Table 16. UAE: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020-2030 (US$ Million)
Table 17. UAE: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020-2030 (US$ Million)
Table 18. UAE: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Application, 2020-2030 (US$ Million)
Table 19. UAE: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by End User, 2020-2030 (US$ Million)
Table 20. Rest of Middle Reat and Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Type, 2020-2030 (US$ Million)
Table 21. Rest of Middle East & Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020-2030 (US$ Million)
Table 22. Rest of Middle East & Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020-2030 (US$ Million)
Table 23. Rest of Middle East & Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020-2030 (US$ Million)
Table 24. Rest of Middle East & Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Application, 2020-2030 (US$ Million)
Table 25. Rest of Middle East and Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by End User, 2020-2030 (US$ Million)
Table 26. Recent Organic Growth Strategies in Middle East & Africa Cell and Gene Therapy Manufacturing Services Market
Table 27. Recent Inorganic Growth Strategies in the Middle East & Africa Cell and Gene Therapy Manufacturing Services Market

List of Figures
Figure 1. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Segmentation, By Country
Figure 2. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Revenue (US$ Mn), 2022 - 2030
Figure 5. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Revenue Share, by Type 2022 & 2030 (%)
Figure 6. Cell Therapy: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Autologous: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Allogenic: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Gene Therapy: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Viral Vector: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Non-Viral Vector: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market, by Indication 2022 & 2030 (%)
Figure 13. Cancer: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Orthopedics: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Others: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Revenue Share, by Application 2022 & 2030 (%)
Figure 17. Clinical Manufacturing: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Commercial Manufacturing: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market Revenue Share, by End User 2022 & 2030 (%)
Figure 20. Pharmaceutical & Biotechnology Companies: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Contract Research Organizations (CROs): Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Middle East & Africa: Cell and Gene Therapy Manufacturing Services Market, by Key Region - Revenue (2022) (US$ Million)
Figure 23. Middle East & Africa: Cell and Gene Therapy Manufacturing Services Market, by Country, 2022 & 2030 (%)
Figure 24. South Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Saudi Arabia: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 26. UAE: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 27. Rest of Middle East & Africa: Middle East & Africa Cell and Gene Therapy Manufacturing Services Market - Revenue and Forecast to 2030 (US$ Million)
Figure 28. Growth Strategies in Middle East & Africa Cell and Gene Therapy Manufacturing Services Market

The List of Companies - Middle East & Africa Cell and Gene Therapy Manufacturing Services Market

1. Lonza Group AG
2. Merck KgaA
3. Nikon Corp
4. Takara Bio Inc
5. Thermo Fisher Scientific Inc
6. WuXi AppTec Co Ltd?